Top of this page
Skip navigation, go straight to the content
Nancy Nackaerts
Director External Communications
Tel: +32 2 559 9264
E-mail: nancy.nackaerts@ucb.com
Cindy Maas
External Communications Specialist
Tel: +32 2 559 9274
E-mail: cindy.maas@ucb.com
Ian Weatherhead
Director UK Corporate Communications
Tel: +44 1753 447950
E-mail: ian.weatherhead@ucb.com
| Country | Contact |
|---|---|
|
Australia |
UCB Pharma |
|
Austria |
UCB Pharma GmbH |
|
Belgium |
UCB Pharma SA |
|
Bulgaria |
UCB BULGARIA EOOD |
|
China |
UCB Representative Office |
|
Czech Republic |
UCB Pharma s.r.o |
|
France |
UCB Pharma SA |
|
Germany |
UCB GmbH |
|
Greece |
UCB Pharma A.E. |
|
Hungary |
UCB Pharma Ltd. |
|
India |
UCB Pharma Limited |
|
Ireland |
UCB (Pharma) Ireland Ltd. |
|
Italy |
UCB Pharma S.p.A. |
|
Japan |
UCB Japan Co. Ltd |
|
Korea |
Korea UCB Co. Ltd |
|
Mexico and |
UCB de Mexico, S.A. de C.V. |
|
New Zealand |
UCB Pharma |
|
Norway |
UCB Pharma A/S |
|
Poland |
UCB Pharma Sp. zo.o. |
|
Portugal |
UCB Pharma (Produtos FarmacĂȘuticos) Lda |
|
Russia |
UCB Representative Office |
|
Scandinavia |
UCB Nordic |
|
Slovakia |
Slovakia UCB o.z. |
|
Spain |
UCB Pharma S.A. |
|
Switzerland |
UCB Pharma AG |
|
the Netherlands |
UCB Pharma BV |
|
Turkey |
UCB Pharma A.S. |
|
United Kingdom |
UCB Pharma Ltd. |
|
USA |
UCB, Inc |
|
|
This contact form is not intended to report health concerns or ask specific questions related to a UCB medicinal product.
In these cases please consult your health care provider. If you are a health care professional and wish to report an adverse event related to a UCB medicinal product, please follow the regulatory procedure in force in your country for adverse event reporting.
The information herein is not intended as a
promotion for any of said medicinal products, but merely as corporate information.